{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:55Z","timestamp":1753891015801,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Asthmatics are more susceptible to viral infections than healthy individuals and are known to have impaired innate anti-viral defences. Influenza A virus causes significant morbidity and mortality in this population. Immuno-modulatory regulators (IMRs) such as PD-1 are activated on T cells following viral infection as part of normal T cell activation responses, and then subside, but remain elevated in cases of chronic exposure to virus, indicative of T cell exhaustion rather than activation. There is evidence that checkpoint inhibition can enhance anti-viral responses during acute exposure to virus through enhancement of CD8+T cell function. Although elevated PD-1 expression has been described in pulmonary tissues in other chronic lung diseases, the role of IMRs in asthma has been relatively unexplored as the basis for immune dysfunction. We first assessed IMR expression in the peripheral circulation and then quantified changes in IMR expression in lung tissue in response to ex-vivo influenza infection. We found that the PD-1 family members are not significantly altered in the peripheral circulation in individuals with severe asthma but are elevated in pulmonary tissues following ex-vivo influenza infection. We then applied PD-1 Mab inhibitor treatment to bronchial biopsy tissues infected with influenza virus and found that PD-1 inhibition was ineffective in asthmatics, but actually increased infection rates in healthy controls. This study, therefore, suggests that PD-1 therapy would not produce harmful side-effects when applied in people with severe asthma, but could have important, as yet undescribed, negative effects on anti-viral responses in healthy individuals that warrant further investigation.<\/jats:p>","DOI":"10.3389\/fimmu.2022.973673","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T06:07:29Z","timestamp":1669010849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunomodulatory regulator blockade in a viral exacerbation model of severe asthma"],"prefix":"10.3389","volume":"13","author":[{"given":"Ben","family":"Nicholas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milenko","family":"Cicmil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Blume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 De Waal","family":"Malefyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratko","family":"Djukanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17252","DOI":"10.1038\/s41598-019-53463-0","article-title":"Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells","volume":"9","author":"Bardhan","year":"2019","journal-title":"Sci Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201504-0782OC","article-title":"Dysregulation of antiviral function of CD8(+) T cells in the chronic obstructive pulmonary disease lung. role of the PD-1-PD-L1 axis","volume":"193","author":"McKendry","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901191","article-title":"Combination immune checkpoint blockade to reverse HIV latency","volume":"204","author":"Van der Sluis","year":"2020","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105703","article-title":"Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules","volume":"9","author":"Raziorrouh","year":"2014","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009894","article-title":"Immunopeptidomic analysis of influenza a virus infected human tissues identifies internal proteins as a rich source of HLA ligands","volume":"18","author":"Nicholas","year":"2022","journal-title":"PloS Pathog"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.307","article-title":"Respiratory infections regulated blood cells IFN-beta-PD-L1 pathway in pediatric asthma","volume":"8","author":"Kolle","year":"2020","journal-title":"Immun Inflammation Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13017","article-title":"Differential regulation of PD-1 and its ligands in allergic asthma","volume":"47","author":"Bratke","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1136\/thx.2008.097741","article-title":"Scottish Intercollegiate guidelines, n. British guideline on the management of asthma","volume":"63","year":"2008","journal-title":"Thorax"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0857OC","article-title":"Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease","volume":"181","author":"Nicholas","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402283","article-title":"A novel lung explant model for the ex vivo study of efficacy and mechanisms of anti-influenza drugs","volume":"194","author":"Nicholas","year":"2015","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809422106","article-title":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis","volume":"106","author":"Huang","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402550","article-title":"NF-kappaB regulates PD-1 expression in macrophages","volume":"194","author":"Bally","year":"2015","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.33","article-title":"Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"38362","DOI":"10.1038\/srep38362","article-title":"PD-1\/PD-L pathway inhibits m.tb-specific CD4(+) T-cell functions and phagocytosis of macrophages in active tuberculosis","volume":"6","author":"Shen","year":"2016","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1086\/499275","article-title":"Expression of programmed death-1 ligand (PD-l) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines","volume":"193","author":"Stanciu","year":"2006","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.10.5538","article-title":"Expression of programmed death 1 ligands by murine T cells and APC","volume":"169","author":"Yamazaki","year":"2002","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0610327","article-title":"Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10","volume":"89","author":"Rodriguez-Garcia","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-271981","article-title":"Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2","volume":"116","author":"Huber","year":"2010","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaci.2016.12.964","article-title":"Susceptibility to influenza virus infection of bronchial biopsies in asthma","volume":"140","author":"Nicholas","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/mi.2012.118","article-title":"Impaired innate interferon induction in severe therapy resistant atopic asthmatic children","volume":"6","author":"Edwards","year":"2013","journal-title":"Mucosal Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jaci.2012.03.044","article-title":"Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients","volume":"129","author":"Sykes","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis b","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5396","article-title":"CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade","volume":"14","author":"Tang","year":"2016","journal-title":"Mol Med Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PloS Pathog"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.973673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T06:07:33Z","timestamp":1669010853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.973673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2022.973673"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.973673","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"article-number":"973673"}}